708-228-0407
Blood-based Biomarkers for Early Diagnosis and Prediction of Drug Efficacy in Cancer & Multiple Sclerosis
US Biomarkers, Inc is a discovery-driven formation-stage company with a proprietary platform for development of blood-based biomarkers using disease-specific epigenetic changes.
We develop blood-based diagnostic tools for early detection of different diseases, when the chances of cure are the highest.
In collaboration with pharmaceutical partners, US Biomarkers, Inc will develop blood-based tests for disease management.
Our goal is a simple, fast, inexpensive and accurate test for disease diagnosis and monitoring.
The Mission
Our mission is to develop and validate clinically useful biomarkers for...
- screening of seemingly healthy people;
- disease detection and diagnosis at the earliest stage;
- prediction of response to therapy (theranostics or personalized medicine);
- monitoring of disease recurrence and prognosis of outcomes.